<!DOCTYPE html>
<html>

  <head>
    <?php include_once '..head.php'; ?>
    <link rel="stylesheet" type="text/css" href="../Header/header-style.css">
    <link rel="stylesheet" type="text/css" href="../common-style.css">
  </head>

  <body>
    <div class = "page-content">

      <?php include_once '../Header/header.php'; ?>

      <div class="page-body">
        <div class="page-title">
          Current Research Studies
        </div>

        <h1>Current Cardiology Projects</h1>
        <ul>
          <li>Development and Evaluation of Novel PET-MR Acquisition and Reconstruction Techniques for Improved Diagnosis of Heart Disease</li>
        </ul>

        <hr>

        <h1>Current Neurology Projects</h1>
        <p>Tracers currently used in our neurology studies include: [<sup>18</sup>F]fallypride, [<sup>18</sup>F]florbetapir, [<sup>18</sup>F]florbetaben, [<sup>18</sup>F]DPA-714, [<sup>18</sup>F]GE-179.</p>
        <ul>
          <li>Tracking myelin changes in vivo with <sup>18</sup>F-florbetapen PET and MRI in patients with Multiple Sclerosis. A Proof of concept Pilot study</li>
          <li>A phase III, randomized, placebo-controlled, parallel-group, double blind clinical trial to study the efficacy and safety of MK-8931 (SCH 900931) in subjects with amnestic Mild Cognitive Impairment due to Alzheimer's Disease (prodromal AD).</li>
          <li>Investigating the role of glutamate and the N-methyl-D-aspartate-Receptor (NMDAR) in brain function</li>
          <li>Investigating the effect of Continuous Positive Airway Pressure on the Neuropathology of Obstructive Sleep Apnoea (INCOSA)</li>
          <li>Dopamine release and blood flow changes during induced epileptic seizures assessed with simultaneous PET-MR</li>
          <li>The role of inflammation in brain and cognitive function in mental disorders (IRIS)</li>
          <li>Evaluation of Brain PET/MR versus PET-CT</li>
        </ul>

        <hr>

        <h1>Current Oncology Projects</h1>
        <p>Tracers currently used in our oncology studies include: [<sup>18</sup>F]FDG, [<sup>18</sup>F]fluoride, [<sup>18</sup>F]choline, [<sup>18</sup>F]MISO, [<sup>68</sup>Ga]PSMA, [<sup>18</sup>F]fluciclovine</p>.
        <ul>
          <li>A Phase 1 Study of LY3039478 in Patients with Advanced or Metastatic Cancer (NOTCH)</li>
          <li>MRI assessment of hypoxia and perfusion in primary colorectal cancer: Correlation with imaging and immunohistochemical markers of hypoxia (MATCH)</li>
          <li>METfomin And Longevity (METAL): A window of opportunity study investigating biological effects of metformin in localised prostate cancer</li>
          <li>A phase 3, open-label study to assess the utility of Fluciclovine (<sup>18</sup>F) Injection PET/CT in patients with prostate cancer with biochemical recurrence after initial treatment - BED007</li>
          <li>A randomized double-blind phase 3 study of avelumab in combination with standard of care chemoradiotherapy (cisplatin plus definitive radiation therapy) versus standard of care chemoradiotherapy in the front-line treatment of patients with locally advanced squamous cell carcinoma of the head and neck - JAVELIN</li>
          <li>An open label, single arm pilot study of OncoSil<sup>TM</sup>, administered to study participants with unresectable locally advanced pancreatic adenocarcinoma, given in combination with FOLFIRINOX or gemcitabine+nab-paclitaxel chemotherapies - OncoSil PANCO </li>
          <li>A pilot study of positron lymphography for pre-operative axillary nodal staging among breast cancer patients</li>
          <li>A Phase 2b Open-label, Randomized Two-arm Study of Selinexor (KPT-330) with Low Dose Dexamethasone in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) - SADAL</li>
          <li>A Phase 1 Adaptive Dose-Escalation Study to Evaluate the Tolerability, Safety, Pharmacokinetics, and Antitumor Activity of ADCT-301 in Patients with Relapsed or Refractory Hodgkin Lymphoma and Non-Hodgkin Lymphoma ADCT-301-001A</li>
          <li>Phase 2, Open-Label, Monotherapy, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement - INCYTE HANK </li>
          <li>TIDaL - Risk-stratified sequential Treatment with Ibrutinib and Rituximab (IR) and IR-CHOP for De-novo post-transplant Lymphoproliferative disorder (PTLD)</li>
          <li>Histological correlation for textural features of PET & CT in NSCLC - FALCON</li>
          <li>First international Inter-Group Study for nodular lymphocyte predominant Hodgkin`s Lymphoma in Children and Adolescents EuroNet-PHL-LP1</li>
          <li>Functional Imaging for Response evaluation assessment in rectal cancer.</li>
          <li>Evaluation of treatment response and resistance in metastatic renal cell cancer (mRCC) using integrated <sup>18</sup>F-Fluorodeoxyglucose (<sup>18</sup>F-FDG) positron emission tomography/magneticresonance imaging (PET/MRI): The REMAP study</li>
          <li>Response evaluation in myeloma patients using integrated 18F-Fluorodeoxyglucose (<sup>18</sup>F-FDG) positron emission tomography/magnetic resonance imaging (PET/MRI): The REVAMP study.</li>
          <li>FABB: B A study using functional imaging biomarkers including <sup>18</sup>F-fluoride PET, <sup>18</sup>FDG PET and DW MRI to assess early treatment response in skeletal metastases from breast cancer.</li>
          <li>FAB P - Functional Assessment of Bone metastases in Prostate cancer</li>
          <li>Improving non-invasive diagnosis and characterisation of prostate cancer with PET/MRI - PROSPER</li>
          <li>Histological correlation for textural features of PET &ceCT in NSCLC</li>
        </ul>

        <hr>

        <h1>Current Osteoporosis Projects</h1>
        <ul>
          <li>An open-label, single centre, pilot study exploring the impact of switching to Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) Fixed Dose Combination (FDC) on regional bone turnover measured using <sup>18</sup>F-PET in HIV-1-infected patients virologically suppressed on Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate (FTC/RPV/TDF). PETRAM</li>
          <li>A randomized, placebo-controlled study to assess the safety, tolerability, pharmacokinetics, and effects on heterotopic bone formation of regn2477 in patients with fibrodysplasia ossificans progressiva - REGENERON FOP</li>
        </ul>

      </div>
      <div class="page-end"></div>
    </div>
  </body>

</html>
